Yanfen Liu

670 total citations · 1 hit paper
25 papers, 440 citations indexed

About

Yanfen Liu is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yanfen Liu has authored 25 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yanfen Liu's work include CAR-T cell therapy research (4 papers), Land Use and Ecosystem Services (3 papers) and Immune Cell Function and Interaction (3 papers). Yanfen Liu is often cited by papers focused on CAR-T cell therapy research (4 papers), Land Use and Ecosystem Services (3 papers) and Immune Cell Function and Interaction (3 papers). Yanfen Liu collaborates with scholars based in China, United States and United Kingdom. Yanfen Liu's co-authors include Jingwen Ai, Liuqing Yang, Kunyong Yu, Jian Liu, Shuangning Yang, Chao Lan, Lili Xiao, Pei Hui, Yi Zhang and Shiwei Duan and has published in prestigious journals such as Scientific Reports, Ecological Indicators and Biomedicine & Pharmacotherapy.

In The Last Decade

Yanfen Liu

24 papers receiving 433 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessing the dynamic landscape ecological risk and its driving forces in an island city based on optimal spatial scales: Haitan Island, China

2022 127 citations Jingwen Ai, Kunyong Yu et al. Ecological Indicators profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanfen Liu China	11	124	124	102	67	43	25	440
Wenjun Wu China	14	129 1.0×	133 1.1×	296 2.9×	114 1.7×	55 1.3×	39	687
Xuedong Li China	17	96 0.8×	69 0.6×	265 2.6×	79 1.2×	147 3.4×	45	736
Jiehong Xie China	13	46 0.4×	58 0.5×	158 1.5×	48 0.7×	94 2.2×	42	464
Mengqian Li China	14	148 1.2×	27 0.2×	160 1.6×	29 0.4×	54 1.3×	21	575
Zhijian Li China	16	43 0.3×	75 0.6×	128 1.3×	46 0.7×	13 0.3×	46	730
Huilong Li China	16	55 0.4×	52 0.4×	102 1.0×	17 0.3×	35 0.8×	60	634
Hongyan Chen China	11	75 0.6×	35 0.3×	69 0.7×	121 1.8×	29 0.7×	34	468
Min Chul Choi South Korea	16	154 1.2×	50 0.4×	213 2.1×	32 0.5×	169 3.9×	62	758
Zhiwei Zhao China	16	121 1.0×	38 0.3×	339 3.3×	55 0.8×	155 3.6×	43	746
Evangelos Papathanasiou United States	14	43 0.3×	26 0.2×	130 1.3×	86 1.3×	29 0.7×	26	883

Countries citing papers authored by Yanfen Liu

Since Specialization

Citations

This map shows the geographic impact of Yanfen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfen Liu more than expected).

Fields of papers citing papers by Yanfen Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfen Liu. The network helps show where Yanfen Liu may publish in the future.

Co-authorship network of co-authors of Yanfen Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfen Liu. A scholar is included among the top collaborators of Yanfen Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfen Liu. Yanfen Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Lili, Yanfen Liu, Xiaoyu Sun, et al.. (2025). Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism. Cancer Biology and Medicine. 22(2). 1–22. 3 indexed citations

Liu, Yanfen, et al.. (2024). The Cardiovascular Benefits of Glucagon-Like Peptide-1 Receptor Agonists as Novel Diabetes Drugs Are Mediated via the Suppression of miR-203a-3p and miR-429 Expression. DNA and Cell Biology. 43(8). 387–394. 3 indexed citations

Liu, Yanfen, Wei Lü, Haiyang Jiang, et al.. (2024). Zinc Transporters Serve as Prognostic Predictors and their Expression Correlates with Immune Cell Infiltration in Specific Cancer: A Pan-cancer Analysis. Journal of Cancer. 15(4). 939–954. 4 indexed citations

Liu, Yanfen, et al.. (2024). Correlation Between Thyroid-Related Hormones and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients with Normal Thyroid Function: A Retrospective Study. Diabetes Metabolic Syndrome and Obesity. Volume 17. 1481–1490. 1 indexed citations

Chen, Xinfeng, Xiaoning Mou, Zhen Zhang, et al.. (2024). PD-1-CD28-enhanced receptor and CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumors. Biomedicine & Pharmacotherapy. 175. 116800–116800. 4 indexed citations

Liu, Yanfen, et al.. (2023). Glp-1 Receptor Agonists Regulate the Progression of Diabetes Mellitus Complicated with Fatty Liver by Down-regulating the Expression of Genes Related to Lipid Metabolism. Applied Biochemistry and Biotechnology. 195(8). 5238–5251. 3 indexed citations

Liu, Yanfen, et al.. (2023). Metagenomic next-generation sequencing for rapid detection of pulmonary infection in patients with acquired immunodeficiency syndrome. Annals of Clinical Microbiology and Antimicrobials. 22(1). 57–57. 5 indexed citations

Zhu, Zhiyu, Yanfen Liu, Wei Lü, et al.. (2023). Diosbulbin C, a novel active ingredient in Dioscorea bulbifera L. extract, inhibits lung cancer cell proliferation by inducing G0/G1 phase cell cycle arrest. BMC Complementary Medicine and Therapies. 23(1). 436–436. 6 indexed citations

Liu, Yanfen, Qi Wang, Xuliang Zhang, et al.. (2022). PINK1/Parkin-mediated mitophagy is activated to protect against AFB1-induced immunosuppression in mice spleen. Toxicology Letters. 366. 33–44. 14 indexed citations

10.

Ai, Jingwen, et al.. (2022). Assessing the dynamic landscape ecological risk and its driving forces in an island city based on optimal spatial scales: Haitan Island, China. Ecological Indicators. 137. 108771–108771. 127 indexed citations breakdown →

11.

Liu, Yanfen, Zhen Zhang, Yonggui Tian, et al.. (2022). Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma. Cytotherapy. 24(5). 526–533. 3 indexed citations

12.

Tian, Yonggui, Zhen Zhang, Yanfen Liu, et al.. (2022). CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy. Cancer Immunology Immunotherapy. 71(11). 2663–2675. 32 indexed citations

13.

Yan, Lili, Zhen Zhang, Yanfen Liu, et al.. (2022). Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology. Frontiers in Molecular Biosciences. 9. 862932–862932. 28 indexed citations

14.

Liu, Yanfen, et al.. (2020). Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges. Clinics. 75. e1277–e1277. 28 indexed citations

15.

Miao, Xuewen, Aili Jiang, Yanfen Liu, et al.. (2020). In vivo biological safety evaluation of an iron-based bioresorbable drug-eluting stent. BioMetals. 33(4-5). 217–228. 16 indexed citations

16.

Jiang, Junjun, Huifang Liu, Abu S. Abdullah, et al.. (2019). An optimal BMI range associated with a lower risk of mortality among HIV-infected adults initiating antiretroviral therapy in Guangxi, China. Scientific Reports. 9(1). 7816–7816. 11 indexed citations

17.

Liu, Yanfen, Xinfeng Chen, Dao Wang, et al.. (2018). Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy. Journal of Immunotherapy. 41(9). 406–410. 36 indexed citations

18.

Huang, Qing, Liyuan Han, Yanfen Liu, et al.. (2017). Elevation of PTPN1 promoter methylation is a significant risk factor of type 2 diabetes in the Chinese population. Experimental and Therapeutic Medicine. 14(4). 2976–2982. 9 indexed citations

19.

Lan, Chao, et al.. (2015). Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Asian Pacific Journal of Cancer Prevention. 16(15). 6569–6573. 59 indexed citations

20.

Liu, Yanfen, et al.. (2008). Land Use/Cover Change Process and Driving Force Analysis in Lianyungang. 23. 600–603. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact